Presence of prelymphoma cells in the bone marrow of the lymphomagenic virus-treated AKR mouse - PubMed (original) (raw)

Comparative Study

. 1984 Mar;44(3):1008-11.

• PMID: 6198077

Comparative Study

Presence of prelymphoma cells in the bone marrow of the lymphomagenic virus-treated AKR mouse

H Takeuchi et al. Cancer Res. 1984 Mar.

Abstract

Prelymphoma cells (PLC) are defined as cells which give rise to lymphoma cells but are not in themselves autonomous. They are present in the bone marrow of young AKR mice, a strain with a high natural incidence of thymic lymphoma. PLC are identified by transfer of AKR bone marrow into 400-rad-treated F1 recipients, one of the parents being AKR. Normal 1-month-old AKR bone marrow cells result in thymic lymphomas of AKR type in the hybrid recipients after latent periods of 6 to 16 months. In the present study, PLC resulting in lymphoma of AKR type 3 to 4 months after inoculation to irradiated hybrids are described. They are consistently found in the bone marrow of 21- to 28-day-old AKR mice treated at 3 to 5 days of age with a lymphomagenic virus, SL3-3. Long-term culture of these bone marrow cells allows the survival of totipotent hemopoietic stem cells but not of PLC. Thymic stromal remnants prepared from the 21- to 28-day-old virus-treated mice efficiently replicate oncogenic virus; however, they do not contain PLC. This was determined by grafting the remnants to irradiated and nonirradiated hybrid recipients. No AKR type lymphomas developed in the grafted mice. We conclude that the bone marrow of young oncogenic virus-treated AKR mice contains PLC modified by oncogenic virus so that they can produce thymic lymphomas after a shorter latent period than can PLC found in 1-month-old normal AKR mice. The modified PLC are not derived from totipotent marrow stem cells or sequestered in the thymic stroma of virus-treated mice.

PubMed Disclaimer

Similar articles

• Development of virus-accelerated thymic lymphoma in AKR mice.
  Kato A, Hays EF. Kato A, et al. J Natl Cancer Inst. 1985 Sep;75(3):491-7. J Natl Cancer Inst. 1985. PMID: 3861900
• AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice.
  Hays EF, Warren J, Hale L, Rodensky D. Hays EF, et al. Exp Hematol. 1980 Jan;8(1):134-46. Exp Hematol. 1980. PMID: 6250871
• Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
  Hays EF, Bristol GC, McDougall S, Klotz JL, Kronenberg M. Hays EF, et al. Cancer Res. 1989 Aug 1;49(15):4225-30. Cancer Res. 1989. PMID: 2545338
• Pre-B lymphomas in SL/Kh mice: a multifactorial disease model.
  Hiai H, Tsuruyama T, Yamada Y. Hiai H, et al. Cancer Sci. 2003 Oct;94(10):847-50. doi: 10.1111/j.1349-7006.2003.tb01365.x. Cancer Sci. 2003. PMID: 14556656 Free PMC article. Review.

Cited by

• Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.
  Rulli K, Lenz J, Levy LS. Rulli K, et al. J Virol. 2002 Mar;76(5):2363-74. doi: 10.1128/jvi.76.5.2363-2374.2002. J Virol. 2002. PMID: 11836414 Free PMC article.
• Tissue distribution and timing of appearance of polytropic envelope recombinants during infection with SL3-3 murine leukemia virus or its weakly pathogenic SL3DeltaMyb5 mutant.
  Rulli K, Lobelle-Rich PA, Trubetskoy A, Lenz J, Levy LS. Rulli K, et al. J Virol. 2001 Jan;75(1):522-6. doi: 10.1128/JVI.75.1.522-526.2001. J Virol. 2001. PMID: 11119621 Free PMC article.
• Thymic dendritic cells are primary targets for the oncogenic virus SL3-3.
  Uittenbogaart CH, Law W, Leenen PJ, Bristol G, van Ewijk W, Hays EF. Uittenbogaart CH, et al. J Virol. 1998 Dec;72(12):10118-25. doi: 10.1128/JVI.72.12.10118-10125.1998. J Virol. 1998. PMID: 9811752 Free PMC article.
• Monoclonal proliferation of Friend murine leukemia virus-transformed myeloblastic cells occurs early in the leukemogenic process.
  Sola B, Heard JM, Fichelson S, Martial MA, Pozo F, Bordereaux D, Gisselbrecht S. Sola B, et al. Mol Cell Biol. 1985 May;5(5):1009-14. doi: 10.1128/mcb.5.5.1009-1014.1985. Mol Cell Biol. 1985. PMID: 4000116 Free PMC article.
• Action site of the gene determining susceptibility to propylnitrosourea-induced thymic lymphomas in F344 rats.
  Shisa H, Suzuki M. Shisa H, et al. Jpn J Cancer Res. 1991 Jan;82(1):46-50. doi: 10.1111/j.1349-7006.1991.tb01744.x. Jpn J Cancer Res. 1991. PMID: 1900267 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information